Stable Liquid Formulations for Viral Vaccines and Gene Therapy Viral Vectors: Reality or Fantasy

3/10/2020 12:15 - 12:50

  • Current pain points and hurdles in vaccine / viral vector DS/DP development
  • Applying a database-driven and algorithm-based formulation development for vaccine & viral vector formulations
  • Formulation case studies on stabilizing vaccines & viral vectors               
  • Future directions for vaccines & viral vectors formulation development

Dr. Andreas Seidl, Chief Operating Officer, LEUKOCARE AG